Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Declaration of H1N1 pandemic to accelerate H1N1 vaccine production

The WHO's decision Thursday to declare H1N1 (swine) flu a pandemic will "speed the production of a vaccine against the new virus," however scientists continue to caution that "it will be fall at the earliest before the first doses are available," the Los Angeles Times reports.

13 Jun 2009

New York Times examines varying definitions of 'pandemic'

"The new swine influenza virus [H1N1], which appeared suddenly after years of warning about a potential pandemic of avian influenza, upset the WHO's assumptions that most people have the same understanding of the word pandemic," says the New York Times in a report that examines the difficultly health experts have had when attempting to agree upon what constitutes a pandemic.

9 Jun 2009

Algae may the key to SARS vaccine

A protein from algae may have what it takes to stop Severe Acute Respiratory Syndrome (SARS) infections, according to new research.

20 May 2009

Swine flu fear now a pandemic

The number of confirmed cases of Swine Flu Fear (SFF) in the United States may have surpassed 100 million amid increasing global anxiety over a menace that authorities around the world are struggling to contain. The increase is not surprising. SFF is highly contagious, and even a brief exposure to someone afflicted can produce the condition.

6 May 2009

Australians warned to remain on guard against 'swine flu'

Even though 91 people have been tested for swine flu in Australia, to date there have been no confirmed cases but health officials are warning Australians not to become complacent and to remain on guard against a possible influenza A(H1N1) - swine-flu - epidemic.

3 May 2009

Flu pandemic long overdue

Here we go again. Just when we thought it was safe to go outside, the threat of another potential flu pandemic raises its head and hysteria builds again. Once again there is talk of quarantine, airport surveillance, travel restrictions and public closures.

29 Apr 2009

Swine flu slows down global economic activity

Concerns about a Swine flu outbreak lowered retail stocks on Monday.

27 Apr 2009

Autoantibodies may be created in response to bacterial DNA

Autoimmune diseases have long been regarded as illnesses in which the immune system creates autoantibodies to attack the body itself. But today, researchers at the California non-profit Autoimmunity Research Foundation (ARF) explain that the antibodies observed in autoimmune disease actually result from alteration of human genes and gene products by hidden bacteria.

27 Apr 2009

Federal funding for partnership to combat infectious diseases

Oregon Health & Science University and the University of Washington, along with a number of partner institutions across the Northwest, have received federal funding to form a regional research center aimed at combating emerging or re-emerging infectious diseases that pose a serious threat to human health.

15 Apr 2009

Hendra and Nipah viruses shown to be susceptible to chloroquine

Two highly lethal viruses that have emerged in recent outbreaks are susceptible to chloroquine, an established drug used to prevent and treat malaria, according to a new basic science study by researchers at Weill Cornell Medical College in the Journal of Virology.

5 Mar 2009

Patented inventions double at University at Buffalo

An antibody with the potential to stop breast cancer in its path. A nanoparticle that can address a side effect of the treatment that hemophiliacs cannot live without. A "quantum dot" with the potential to treat cancer or harvest the power of the sun. An air purifier that kills the world's nastiest toxins.

5 Mar 2009

Experts warn Australia is surrounded by a ring of disease hot-spots

Australian biosecurity experts have warned that Australia is surrounded to its north by a 'ring of fire' where new human and animal plagues could appear with very little warning and with potentially dire consequences.

6 Jan 2009

DNA vaccine for SARS achieves neutralizing responses in first U.S. human trial

Vical Incorporated (NASDAQ:VICL) today announced that results from a Phase I clinical trial of a DNA vaccine for severe acute respiratory syndrome (SARS), conducted by the National Institutes of Health (NIH) and published in the November 25 issue of Vaccine(1), demonstrated that the vaccine was well-tolerated, and induced neutralizing antibody responses in 80% of the vaccinees and T-cell immune responses in all vaccinees.

10 Dec 2008